Page last updated: 2024-08-18

isomethyleugenol and Histiocytoma, Malignant Fibrous

isomethyleugenol has been researched along with Histiocytoma, Malignant Fibrous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Antonescu, CR; Bale, TA; Benayed, R; Benhamida, JK; Dermawan, JK; Dickson, BC; Herviou, L; Singer, S; Sung, YS; Tap, WD; Vanoli, F; Zhang, L	1

Other Studies

1 other study(ies) available for isomethyleugenol and Histiocytoma, Malignant Fibrous

Article	Year
Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022, Volume: 35, Issue:8 Topics: Genomics; Histiocytoma, Malignant Fibrous; Humans; Methylation; Mutation; Oncogene Proteins, Fusion; RNA-Binding Protein EWS; RNA-Binding Protein FUS; Translocation, Genetic	2022

Article

Year

Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022, Volume: 35, Issue:8

Topics: Genomics; Histiocytoma, Malignant Fibrous; Humans; Methylation; Mutation; Oncogene Proteins, Fusion; RNA-Binding Protein EWS; RNA-Binding Protein FUS; Translocation, Genetic

2022